AAAAAA

   
Results: 1-4 |
Results: 4

Authors: TRUNET PF VREELAND F ROYCE C CHAUDRI HA COOPER J BHATNAGAR AS
Citation: Pf. Trunet et al., CLINICAL USE OF AROMATASE INHIBITORS IN THE TREATMENT OF ADVANCED BREAST-CANCER, Journal of steroid biochemistry and molecular biology, 61(3-6), 1997, pp. 241-245

Authors: SIOUFI A GAUDUCHEAU N PINEAU V MARFIL F JAOUEN A CARDOT JM GODBILLON J CZENDLIK C HOWALD H PFISTER C VREELAND F
Citation: A. Sioufi et al., ABSOLUTE BIOAVAILABILITY OF LETROZOLE IN HEALTHY POSTMENOPAUSAL WOMEN, Biopharmaceutics & drug disposition, 18(9), 1997, pp. 779-789

Authors: BURRIS H IRVIN R KUHN J KALTER S SMITH L SHAFFER D FIELDS S WEISS G ECKARDT J RODRIGUEZ G RINALDI D WALL J COOK G SMITH S VREELAND F BAYSSAS M LEBAIL N VONHOFF D
Citation: H. Burris et al., PHASE-I CLINICAL-TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR6-HOUR INTRAVENOUS-INFUSION, Journal of clinical oncology, 11(5), 1993, pp. 950-958

Authors: BALTZER L KRIS MG TYSON LB RIGAS JR VREELAND F PISTERS KMW
Citation: L. Baltzer et al., DOSE-RANGING ANTIEMETIC EVALUATION OF THE SEROTONIN ANTAGONIST RG-12915 IN PATIENTS RECEIVING ANTICANCER CHEMOTHERAPY, Cancer, 72(9), 1993, pp. 2695-2699
Risultati: 1-4 |